ABCL
AbCellera Biologics Inc.
NASDAQ · Healthcare · Biotechnology · CA
$11.43
−1.21%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 135.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.13x
- Price / sales
- 55.97x
- Price / cash flow
- -23.94x
Enterprise value
- Enterprise value
- $3.3B
- EV / sales
- 49.86x
- EV / EBITDA
- -20.58x
- EV / EBIT
- -14.65x
- Market cap
- $3.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026